Mangoceuticals, Inc. (MGRX) は上場企業です ヘルスケア セクターの Medical - Healthcare Information Services 業界で事業展開. 本社所在地は Dallas, TX, アメリカ. 現CEOは Jacob D. Cohen.
MGRX を有する IPO日 2023-03-21, 3 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $3.93M.
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
